Many physiologic effects of l-glutamate, the major excitatory neurotransmitter in the
mammalian central nervous system, are mediated via signaling by ionotropic glutamate …

The realization that autoantibodies can contribute to dysfunction of the brain has brought
about a paradigm shift in neurological diseases over the past decade, offering up important …

Investigations in the last 10 years have revealed a new category of neurological diseases
mediated by antibodies against cell surface and synaptic proteins. There are currently 16 …

Autoimmune diseases (AID) are increasingly prevalent conditions which comprise more
than 100 distinct clinical entities that are responsible for a great disease burden worldwide …

The discovery, in 2010, of autoantibodies against the extracellular proteins LGI1 and Caspr2
facilitated a change of view regarding the clinical importance of voltage-gated potassium …

Autoimmune encephalitides (AIE) comprise a group of inflammatory diseases of the central
nervous system (CNS), which can be further characterized by the presence of different …

The rapid expansion in the number of encephalitis disorders associated with autoantibodies
against neuronal proteins has led to an incremental increase in use of the term “autoimmune …

Objective: We report the clinical features, comorbidities, and outcome of 22 newly identified
patients with antibodies to the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid …

Investigations during the last 10 years have revealed a group of disorders mediated by
antibodies against ion channels and synaptic receptors, which cause both neurologic and …

Activity-dependent synaptic plasticity has since long been proposed to represent the
subcellular substrate of learning and memory, one of the most important behavioral …